Weight and pregnancy outcomes after GLP-1 use
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at how a type of weight-loss medication called GLP-1 affects pregnancy and baby outcomes. It aims to learn if this medication is safe to use early in pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman
- You are 18 years old or older
- You are less than 20 weeks pregnant at your first check-up
- You can read and speak English
- You do not have type 2 diabetes
- You have not had weight-loss surgery
- You are pregnant with only one baby
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether taking GLP-1 medications (commonly used for diabetes or weight loss) can improve gum health and the response to standard non-surgical gum disease treatment. If you are on a GLP-1 drug and have gum disease, this trial may help determine if your treatment works better.
This trial compares different ways to keep weight off after you've lost weight using a GLP-1 medication, like semaglutide or tirzepatide. It tests reducing your GLP-1 dose and adding other weight loss medications to help maintain your progress.
This study looks at how your body composition (muscle and fat) changes after you start a GLP-1 medication for obesity or type 2 diabetes. You will be followed for a year with body scans to see the effects.
This study tests whether a type of diabetes/weight loss medication (GLP-1 RA, given as a shot) affects milk production in breastfeeding mothers. It may help women who need this medicine while nursing.
This study looks at how starting a GLP-1 medication (like Wegovy or Ozempic) changes your food choices and eating habits. It may help you understand if these medicines work for weight loss.
This trial tests whether adding a GLP-1 medication (a type of diabetes and weight-loss drug) after weight-loss surgery helps patients with obesity and related health conditions like diabetes. Researchers want to see if combining surgery with this medicine works better than surgery alone.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.